# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Charlotte Brontë (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI025-SYN
- Date: 2026-02-10
- Fictional facility: St. Posthumous Health Center
- Fictional author: Eleanor Thwaite, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Review at 11 weeks, nine days after discharge from an admission for hyperemesis gravidarum. **S**

## History of present illness

Ms. Brontë returns at 11 weeks 1 day. After the sick visit she was admitted for three nights for intravenous saline with potassium, thiamine, magnesium, ondansetron, and enoxaparin, and went home nine days ago keeping down fluids, food, and tablets. She takes ondansetron 4 mg every 8 hours, doxylamine-pyridoxine four tablets a day, and thiamine 100 mg three times a day. She now vomits once a day or less and eats five small meals a day. Her PUQE-24 score is 9. She has mild constipation since starting ondansetron, which she manages with fluids, prunes, and oat bran. She has had no headache, palpitations, pain, or bleeding. She felt low and frightened in the hospital and is now more hopeful. The planned electrolyte check within a week of discharge was not done; blood was drawn today. **S**

| Element | Detail |
|---|---|
| Hospital course | Three nights: intravenous fluids, potassium, magnesium, thiamine, ondansetron, enoxaparin |
| Interval change | Vomiting once a day or less; five small meals a day |
| PUQE-24 | 9 (moderate), down from 14 |
| Side effects | Mild constipation on ondansetron |
| Mood | More hopeful; EPDS 9 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Gastrointestinal | Positive | Nausea in the mornings; vomiting once a day or less; mild constipation |
| Cardiovascular | Negative | No palpitations or fainting |
| Neurological | Negative | No headache, confusion, or unsteadiness |
| Genitourinary | Negative | No bleeding or urinary symptoms |
| Psychiatric | Positive | Was low and frightened in hospital; more hopeful now; no thoughts of self-harm |

5 systems reviewed. **S**

## Current medications

- Folic acid 0.4 mg oral tablet, one tablet by mouth daily (replacing an iron-containing prenatal vitamin while nausea is severe) **S**
- Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, one tablet in the morning, one mid-afternoon, and two at bedtime (four a day) **S**
- Ondansetron 4 mg orally disintegrating tablet, one tablet every 8 hours **S**
- Thiamine 100 mg oral tablet, one tablet by mouth three times a day **S**

## Allergies

- No known allergy **S**

## Objective

BP 104/64 mmHg; pulse 86 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 43.6 kg; BMI 18.9 kg/m². All vital signs are synthetic.

Sodium: 137 mmol/L; Potassium: 4 mmol/L; Chloride: 101 mmol/L; Bicarbonate (total CO2): 25 mmol/L; BUN: 9 mg/dL; Creatinine: 0.55 mg/dL; Glucose: 82 mg/dL; Magnesium: 1.9 mg/dL; Phosphate: 3.4 mg/dL; ALT: 31 U/L; AST: 24 U/L; EPDS: 9. All results are synthetic.

## Change since baseline

- Sodium: 137 mmol/L at baseline, 137 mmol/L at this visit **S**
- Potassium: 3.9 mmol/L at baseline, 4 mmol/L at this visit **S**
- Chloride: 102 mmol/L at baseline, 101 mmol/L at this visit **S**
- Bicarbonate (total CO2): 24 mmol/L at baseline, 25 mmol/L at this visit **S**
- BUN: 8 mg/dL at baseline, 9 mg/dL at this visit **S**
- Creatinine: 0.52 mg/dL at baseline, 0.55 mg/dL at this visit **S**
- Glucose: 76 mg/dL at baseline, 82 mg/dL at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Slight; better color; comfortable |
| Hydration | Moist mucous membranes; pulse 86 |
| Abdomen | Soft and non-tender; uterus just palpable above the pubic bone |
| Fetal | Fetal heart heard by handheld Doppler at 158 per minute |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Hyperemesis gravidarum, improving** (O21.1). PUQE-24 score 9, down from 14; weight 43.6 kg, up 1.0 kg from the sick visit. Sodium 137, potassium 4.0, chloride 101, bicarbonate 25 mmol/L, urea nitrogen 9, creatinine 0.55, glucose 82, magnesium 1.9, and phosphate 3.4 mg/dL: normal, with no fall in phosphate after refeeding. ALT 31 and AST 24 U/L are back to normal. The post-discharge electrolyte check was late; today's results show no harm. **S**
   - Continue ondansetron 4 mg every 8 hours, doxylamine-pyridoxine four tablets a day, and thiamine 100 mg three times a day until she eats regular meals.
   - Constipation: fluids, fiber, and prunes; an osmotic laxative if needed.
   - No thromboprophylaxis now: age over 35 is her only persisting risk factor; reassess at 28 weeks and at any admission.
2. **Gestational transient thyrotoxicosis** (O99.281). No palpitations or tremor; pulse 86. **S**
   - Repeat TSH and free T4 at 16 to 18 weeks.
3. **First pregnancy at 38** (O09.519). Fetal heart 158 per minute. EPDS 9 with item 10 scored 0: below the threshold, with understandable distress after the admission. **S**
   - Cell-free DNA screening drawn today.
   - Nuchal translucency scan in two weeks.
   - Offered the clinic's perinatal support group and a counselor; she will join the support group.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PUQE-24 score (recorded in the note; no LOINC code found) | Every visit while nausea and vomiting last | Completed today | 9 (moderate), down from 14 at the sick visit |
| Examination | Weight against pre-pregnancy weight (46.0 kg), pulse, blood pressure, and hydration | Every visit while nausea and vomiting last | Completed today | 43.6 kg, up 1.0 kg; pulse 86; well hydrated |
| Laboratory | Electrolytes, urea nitrogen, creatinine, and glucose | When vomiting is moderate or severe, daily while on intravenous fluids, and until stable on oral intake | Completed today | Normal |
| Laboratory | Electrolytes within a week of discharge | Once, within seven days of discharge | Deferred | Missed: the check planned for within a week of discharge was not booked, and the first post-discharge electrolytes were drawn today, nine days after discharge. No harm: all results today are normal. Corrective action: discharge orders for hyperemesis now include a booked laboratory appointment |
| Laboratory | Magnesium and phosphate (refeeding risk) | During admission and after refeeding begins | Completed today | Magnesium 1.9 and phosphate 3.4 mg/dL: normal; no refeeding drop |
| Laboratory | ALT and AST | Until normal if raised | Completed today | ALT 31 and AST 24 U/L: normal |
| Laboratory | TSH and free T4 | In hyperemesis gravidarum; repeat at 16 to 18 weeks if suppressed | Due | Suppressed at the sick visit; repeat planned at 16 to 18 weeks |
| Medication safety | Antiemetic effects: constipation, headache, and palpitations with ondansetron; drowsiness with doxylamine-pyridoxine | Every visit and after each change | Completed today | Mild constipation only |
| Medication safety | Thiamine while intake is poor | From admission until regular meals | Completed today | 100 mg three times a day; no signs of Wernicke encephalopathy |
| Examination | Venous thromboembolism risk assessment | At every admission and discharge, and at 28 weeks | Completed today | Age over 35 is her only persisting risk factor; no prophylaxis now |
| Survey | Perinatal mood screen | Each trimester and after any admission | Completed today | EPDS 9; item 10 scored 0 |
| Laboratory | Cell-free DNA screening | From 10 weeks, as she chose | Ordered | Drawn today; result in about a week |
| Examination | Blood pressure | Every prenatal visit | Completed today | 104/64 mmHg |
| Examination | Fetal heart | Every prenatal visit | Completed today | 158 per minute by Doppler |

## Goal progress

- Nausea and vomiting mild (PUQE-24 score 6 or less) and weight back to her pre-pregnancy 46.0 kg by about 17 weeks. In progress; target 2026-03-24. **S**
- Hydration and electrolytes normal within two weeks of any admission. Outcome by 2026-02-10: Sodium, potassium, chloride, bicarbonate, magnesium, phosphate, and transaminases all normal nine days after discharge. **S**
- An informed choice about aneuploidy screening and diagnostic testing by 13 weeks. In progress; target 2026-02-24. **S**
- Low-dose aspirin started between 12 and 16 weeks if indicated. In progress; target 2026-02-24. **S**
- Tuberculosis screening completed and explained by the second visit. Outcome by 2026-01-20: Interferon-gamma release assay negative; no latent infection; no chest radiograph needed. **S**
- Mood screened in each trimester, with support offered. In progress; target 2026-03-24. **S**

## Guideline basis

- ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69) (2024), Royal College of Obstetricians and Gynaecologists (BJOG)
- Reducing the Risk of Thrombosis and Embolism during Pregnancy and the Puerperium (Green-top Guideline No. 37a) (2015), Royal College of Obstetricians and Gynaecologists
- Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum (Clinical Practice Guideline No. 4) (2023), American College of Obstetricians and Gynecologists

## Follow-up

- Prenatal visit with the nuchal translucency scan in two weeks, at 13 weeks. **S**
- Next scheduled visit 2026-02-24: prenatal visit at 13 weeks with the nuchal translucency scan and the low-dose aspirin decision. **S**
